KCM
ZYME icon

Kennedy Capital Management’s Zymeworks ZYME Stock Holding History

Kennedy Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8M Sell
145,386
-2,840
-2% -$72.2K 0.07% 365
2026
Q1 		$3.71M Buy
148,226
+2,692
+2% +$63.7K 0.08% 344
2025
Q4 		$3.83M Sell
145,534
-906
-0.6% -$19.8K 0.08% 339
2025
Q3 		$2.5M Sell
146,440
-514
-0.3% -$7.36K 0.06% 415
2025
Q2 		$1.84M Buy
146,954
+10,635
+8% +$127K 0.04% 451
2025
Q1 		$1.62M Sell
136,319
-3,634
-3% -$49.6K 0.04% 454
2024
Q4 		$2.05M Sell
139,953
-3,627
-3% -$50.7K 0.05% 512
2024
Q3 		$1.8M Sell
143,580
-1,942
-1% -$21.1K 0.04% 531
2024
Q2 		$1.24M Sell
145,522
-8,840
-6% -$78.7K 0.03% 570
2024
Q1 		$1.62M Sell
154,362
-1,672
-1% -$18.6K 0.03% 554
2023
Q4 		$1.62M Sell
156,034
-2,641
-2% -$21K 0.04% 531
2023
Q3 		$1.01M Buy
158,675
+73,746
+87% +$545K 0.02% 562
2023
Q2 		$734K Buy
84,929
+6,452
+8% +$57.8K 0.02% 576
2023
Q1 		$709K Buy
78,477
+52
+0.1% +$453 0.02% 523
2022
Q4 		$616K Buy
78,425
+31
+0% +$218 0.02% 540
2022
Q3 		$482K Buy
78,394
+38,503
+97% +$232K 0.01% 552
2022
Q2 		$211K Sell
39,891
-103,077
-72% -$623K 0.01% 587
2022
Q1 		$936K Sell
142,968
-57,070
-29% -$509K 0.02% 509
2021
Q4 		$3.28M Buy
200,038
+163,571
+449% +$3.41M 0.07% 403
2021
Q3 		$1.06M Buy
+36,467
New +$1.21M 0.02% 519

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Kennedy Capital Management's ZYME Position: Q2 2026 in Review

Kennedy Capital Management reduced its Zymeworks (ZYME) stake by 1.9% in Q2 2026, selling an estimated $72.2K and leaving 145,386 shares worth $3.8M. The position accounts for 0.07% of the portfolio, ranked #365.

Kennedy Capital Management first reported a position in ZYME in Q3 2021 and has held it in 20 quarters since. The position peaked at $3.83M in Q4 2025. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Kennedy Capital Management held 145,386 shares of Zymeworks worth $3.8M as of Q2 2026.
  • Kennedy Capital Management sold 2,840 Zymeworks shares in Q2 2026, an estimated $72.2K.
  • Zymeworks made up 0.07% of Kennedy Capital Management's portfolio in Q2 2026, its #365 holding.
  • Kennedy Capital Management first reported a position in Zymeworks in Q3 2021 and has held it in 20 quarters since.
  • Kennedy Capital Management's Zymeworks position peaked at $3.83M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.